請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6539
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山 | |
dc.contributor.author | Yi-Ting Chen | en |
dc.contributor.author | 陳宜婷 | zh_TW |
dc.date.accessioned | 2021-05-17T09:14:31Z | - |
dc.date.available | 2017-09-19 | |
dc.date.available | 2021-05-17T09:14:31Z | - |
dc.date.copyright | 2012-09-19 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-08-15 | |
dc.identifier.citation | 1. Clarke, J.K. On the bacterial factor in the aetiology of dental caries. Br J Exp Pathol 5, 141-147 (1924).
2. Hamada S, S.H. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44, 331-384 (1980). 3. Liu, C., Worthington, R.J., Melander, C. & Wu, H. A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms. Antimicrob Agents Chemother 55, 2679-87 (2011). 4. Mitchell, T.J. The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 1, 219-30 (2003). 5. Kazuhiko Nakano, R.N., Takashi Ooshima. Streptococcus mutans and cardiovascular diseases. Japanese Dental Science Review 44, 29-37 (2008). 6. Flemming, H.C. & Wingender, J. The biofilm matrix. Nat Rev Microbiol 8, 623-33 (2010). 7. Hall-Stoodley, L., Costerton, J.W. & Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2, 95-108 (2004). 8. Abee, T., Kovacs, A.T., Kuipers, O.P. & van der Veen, S. Biofilm formation and dispersal in Gram-positive bacteria. Curr Opin Biotechnol 22, 172-9 (2011). 9. Que, Y.A. & Moreillon, P. Infective endocarditis. Nat Rev Cardiol 8, 322-36 (2011). 10. Moreillon, P. & Que, Y.A. Infective endocarditis. Lancet 363, 139-49 (2004). 11. Fekete, T. Controversies in the prevention of infective endocarditis related to dental procedures. Dent Clin North Am 34, 79-90 (1990). 12. Hetzer, R. & Hummell, M. Thromboembolism and endocarditis--it's not simply the vegetation. Eur Heart J 22, 811-2 (2001). 13. Cabell, C.H., Abrutyn, E. & Karchmer, A.W. Cardiology patient page. Bacterial endocarditis: the disease, treatment, and prevention. Circulation 107, e185-7 (2003). 14. Jung, C.J., Zheng, Q.H., Shieh, Y.H., Lin, C.S. & Chia, J.S. Streptococcus mutans autolysin AtlA is a fibronectin-binding protein and contributes to bacterial survival in the bloodstream and virulence for infective endocarditis. Mol Microbiol 74, 888-902 (2009). 15. Chia, J.S., Lee, Y.Y., Huang, P.T. & Chen, J.Y. Identification of stress-responsive genes in Streptococcus mutans by differential display reverse transcription-PCR. Infect Immun 69, 2493-501 (2001). 16. Fitzgerald, J.R., Foster, T.J. & Cox, D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 4, 445-57 (2006). 17. McNicol, A. & Israels, S.J. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol 88, 510-24 (2010). 18. Moreillon, P. et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63, 4738-43 (1995). 19. Chia, J.S., Lin, Y.L., Lien, H.T. & Chen, J.Y. Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans. Infect Immun 72, 2605-17 (2004). 20. Matsumoto-Nakano, M. et al. Contribution of cell surface protein antigen c of Streptococcus mutans to platelet aggregation. Oral Microbiol Immunol 24, 427-30 (2009). 21. Kerrigan, S.W. et al. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 75, 5740-7 (2007). 22. Jung, C.J. et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. J Infect Dis 205, 1066-75 (2012). 23. Rammelkamp, C.H. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal Infections. Circulation 15 (1957). 24. Wilson, W. et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116, 1736-54 (2007). 25. Khan, I.A. & Ijaz, N. Prophylaxis of infective endocarditis: current perspectives. Int J Cardiol 134, e105-6 (2009). 26. Oliver, R., Roberts, G.J., Hooper, L. & Worthington, H.V. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev, CD003813 (2008). 27. Duval, X. & Leport, C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 8, 225-32 (2008). 28. McDougald, D., Rice, S.A., Barraud, N., Steinberg, P.D. & Kjelleberg, S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol 10, 39-50 (2012). 29. Sawyer, L.K. & Hermanowicz, S.W. Detachment of Aeromonas hydrophila and Pseudomonas aeruginosa due to variations in nutrient supply. Water Science and Technology 41, 139-145 (2000). 30. James, G.A., Korber, D.R., Caldwell, D.E. & Costerton, J.W. Digital image analysis of growth and starvation responses of a surface-colonizing Acinetobacter sp. J Bacteriol 177, 907-15 (1995). 31. An, S., Wu, J. & Zhang, L.H. Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-Di-GMP phosphodiesterase with a putative hypoxia-sensing domain. Appl Environ Microbiol 76, 8160-73 (2010). 32. Qi, F. et al. Peptide pheromone induced cell death of Streptococcus mutans. FEMS Microbiol Lett 251, 321-6 (2005). 33. Eckert, R. et al. Targeted killing of Streptococcus mutans by a pheromone-guided 'smart' antimicrobial peptide. Antimicrob Agents Chemother 50, 3651-7 (2006). 34. Allison, D.G., Ruiz, B., SanJose, C., Jaspe, A. & Gilbert, P. Extracellular products as mediators of the formation and detachment of Pseudomonas fluorescens biofilms. FEMS Microbiol Lett 167, 179-184 (1998). 35. Schooling S, C.U., Allison DG, Gilbert P. A role for rhamnolipid in biofilm dispersion. Biofilms 1 (2004). 36. Sillankorva, S., Neubauer, P. & Azeredo, J. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling 26, 567-75 (2010). 37. Lam, H. et al. D-amino acids govern stationary phase cell wall remodeling in bacteria. Science 325, 1552-5 (2009). 38. Kolodkin-Gal, I. et al. D-amino acids trigger biofilm disassembly. Science 328, 627-9 (2010). 39. Kolodkin-Gal, I. et al. A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 149, 684-692 (2012). 40. Aberg, V. & Almqvist, F. Pilicides-small molecules targeting bacterial virulence. Org Biomol Chem 5, 1827-34 (2007). 41. Pinkner, J.S. et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci U S A 103, 17897-902 (2006). 42. Cegelski, L. et al. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5, 913-9 (2009). 43. Born, G.V. & Cross, M.J. The aggregation of blood platelets. J Physiol 168, 178-95 (1963). 44. Michelson, A.D. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 9, 154-69 (2010). 45. Pepin, J. et al. Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clinical Microbiology and Infection 15, 193-199 (2009). 46. Shibata, Y. et al. Streptococcus mutans diacylglycerol kinase homologue: a potential target for anti-caries chemotherapy. J Med Microbiol 60, 625-30 (2011). 47. Van Horn, W.D. & Sanders, C.R. Prokaryotic diacylglycerol kinase and undecaprenol kinase. Annu Rev Biophys 41, 81-101 (2012). 48. Yamashita, Y., Takehara, T. & Kuramitsu, H.K. Molecular characterization of a Streptococcus mutans mutant altered in environmental stress responses. J Bacteriol 175, 6220-8 (1993). 49. Li, Z., Delaney, M.K., O'Brien, K.A. & Du, X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 30, 2341-9 (2010). 50. Werner, M.H., Senzel, L., Bielawska, A., Khan, W. & Hannun, Y.A. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. Mol Pharmacol 39, 547-56 (1991). 51. Yoshida, K., Asaoka, Y. & Nishizuka, Y. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids. Proc Natl Acad Sci U S A 89, 6443-6 (1992). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6539 | - |
dc.description.abstract | 感染性心內膜炎(infective endocarditis)是一種高致死率、高復發率的心血管感染疾病,主要由一些口腔中的鏈球菌例如:轉糖鏈球菌(Streptococcus mutans)所引發。這些會引起心內膜炎的致病株可在受傷的瓣膜上形成生物膜(biofilm),並與血小板、纖維蛋白(fibrin)及發炎細胞堆疊成贅疣(vegetation)。目前治療的潛在問題是這些在贅疣中形成生物膜的致病株具有高抗藥性。先前實驗室曾利用體外篩選模式(in vitro)模擬體內產生贅疣的狀況,證實血小板對於轉糖鏈球菌生成生物膜是重要的、以及所生成的生物膜對於抗生素具有更高的抗性,因此有必要進一步尋找一些小分子合成物來輔助抗生素抑制生物膜形成。本篇研究藉由體外生成生物膜的方法,並搭配結晶紫(crystal violet)的染色,篩選出CYY-X022, 47, 48, 58, 60五種小分子合成物能夠抑制細菌形成生物膜,而CYY-X011, 12, 22, 47, 52, 55, 56則可以干擾由細菌和血小板所形成的生物膜的生成。進一步測定細菌生長曲線,發現CYY-X022, 47, 48, 58, 60能有效地抑制細菌生長。利用血小板凝集計(aggregometer) 分析血小板活性以及測定細菌和血小板之間交互作用的狀況,發現CYY-X011, 12, 22, 47, 52, 55, 56能夠藉由干擾細菌和血小板之間的接觸來抑制血小板凝集,進而抑制由細菌和血小板所形成的生物膜。在活體 (in vivo) 實驗中,利用實驗室先前所建立的感染性心內膜炎大鼠模式(experimental streptococcal endocarditis rat model),將CYY-X022, 47, 52, 55, 56分別注入大鼠體內,發現能夠降低贅疣中生物膜生成的狀況。除此之外,當抗生素搭配小分子一同使用,利用共軛焦顯微鏡的觀察以及菌落的計數,發現抑制效果比給予單一抗生素處理還要好。本篇研究結果篩選出具有抑制生物膜生成的小分子合成物,希望對於未來在感染性心內膜炎的治療上能夠提供重要的資訊,並且能夠在其他臨床的研究上也有更多的應用。 | zh_TW |
dc.description.abstract | Infective endocarditis (IE) is a cardiovascular disease with high mortality rate and usually caused by oral streptococci (such as Streptococcus mutans) infection. The characteristic of IE is the formation of vegetations, fibrin-platelet clots with the embedded bacteria forming biofilm, which is refractory to routine antibiotic treatment. Previously, our data reported that platelets play important roles in vegetation formation and could enhance the resistance of streptococcal biofilm to antibiotics. Therefore, to search novel prophylactic agents that specifically target the platelet-associated biofilm will provide effective strategy for the successful control of IE. In this study, 76 different synthetic molecules have been screened in vitro by using biofilm formation assay and crystal violet staining. We found that CYY-X022, 47, 48, 58 and 60 could eliminate homotypic bacterial biofilm formation, and CYY-X011, 12, 22, 47, 52, 55 and 56 could interfere with platelet-associated biofilm formation. Among these effective synthetic molecules, CYY-X022, 47, 48, 58 and 60 could inhibit the bacterial growth , and CYY-X011, 12, 22, 47, 52, 55 and 56, alternatively, could interfere with the binding of S. mutans and platelets, as well as inhibiting the streptococci-induced platelet aggregation according to the results of platelet aggregation test. Consistent with the in vitro data, the vegetation size was decreased by intravenous administration of CYY-X022, 47, 52, 55 and 56 in the experimental streptococcal endocarditis rat model. Moreover, antibiotics combined with the targeted small molecules in vitro could effectively inhibit the biofilm formation based on the results of confocal laser scanning microscope observation and the measurement of survival bacteria. Taken together, the data suggest that these synthetic small molecules could eliminate streptococcal biofilm formation by inhibiting the bacterial growth or the binding of S. mutans and platelets. For clinical treatment on infective endocarditis, these targeted small molecules may have promising applications and offer another strategy. | en |
dc.description.provenance | Made available in DSpace on 2021-05-17T09:14:31Z (GMT). No. of bitstreams: 1 ntu-101-R99445132-1.pdf: 3477955 bytes, checksum: c9a75b94d5cdc7c9c993a5c54708aeec (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii Abstract iv Chapter 1: Introduction 1 1.1 Streptococcus mutans 1 1.2 Infective endocarditis (IE) 2 1.3 The role of platelets in IE model 3 1.4 Prophylaxis treatment 5 1.5 Biofilm dispersal 6 1.5.1 Dispersal factors 7 1.5.2 D-amino acids 8 1.5.3 Small molecules 9 1.6 Specific aim 10 Chapter 2: Materials and Methods 12 2.1 Bacteria strains and culture 12 2.2 Preparation of human platelets 12 2.2.1 Platelet-rich plasma (PRP) 12 2.2.2 Platelet-poor plasma (PPP) 13 2.2.3 Platelet suspension (PS) 13 2.3 Preparation of small molecules 13 2.4 Biofilm formation assay 14 2.5 Bacteriostatic analysis 15 2.6 Platelet aggregation test 16 2.7 Bacteria-platelet interacting assay 17 2.8 Experimental streptococcal endocarditis rat model 18 2.8.1 Experimental schedule design 18 2.8.2 Preparation for bacteria, small molecules and anesthetic 19 2.8.3 Cardiac catheterization 19 2.8.4 Quantification and observation 19 2.8 Confocal laser scanning microscopy (CLSM) analysis 20 Chapter 3: Results 21 3.1 Identification of streptococci-platelet biofilm specific inhibitors 21 3.2 The correlation between small molecules concentration and bacterial number in inhibition effect 22 3.3 The effect of targeted small molecules on bacteria growth 23 3.4 Inhibition effect of targeted small molecules on bacteria-induced platelet aggregation 24 3.5 Inhibition effect of targeted small molecules on bacteria adherence to platelets 25 3.6 Inhibition effect of targeted small molecules on biofilm formation in rat endocarditis model 27 3.7 Synergistic effect with antibiotics 28 Chapter 4: Discussion 29 4.1 Summary 29 4.2 The inhibiting effect of the targeted small molecules on biofilm formation 31 4.3 Application of small molecules as biofilm dispersal factors 35 Chapter 5: References 37 Chapter. 6 Figures 43 Fig. 1. Identification of streptococci-platelet biofilm specific inhibitors by crystal violet staining. 44 Fig. 2. Identification of streptococci-platelet biofilm specific inhibitors by confocal laser scanning microscopy 46 Fig. 3. The correlation between small molecules concentration and bacterial number in inhibition effect 49 Fig. 4. The effect of targeted small molecules on bacteria growth 50 Fig. 5. Inhibition effect of targeted small molecules on bacteria-induced platelet aggregation 52 Fig. 6. The diagram of bacteria-platelet interacting assay 53 Fig. 7. Inhibition effect of targeted small molecules on bacteria adherence to platelets 55 Fig. 8. Inhibition effect of targeted small molecules on biofilm formation in rat endocarditis model 57 Fig. 9. Synergistic effect with antibiotics 59 Chapter. 7 Appendix 60 Appendix. 1. The pathogenesis of streptococcal-induced infective endocarditis. 60 Appendix. 2. The mechanism of S. aureus-mediated platelet activation 61 Appendix. 3. The mechanisms of oral bacteria-induced platelet activation 62 Appendix. 4. The dispersal factors 62 | |
dc.language.iso | en | |
dc.title | 小分子合成物對於會引起心內膜炎的鏈球菌的生物膜形成之抑制作用 | zh_TW |
dc.title | Inhibition of endocarditis-inducing streptococcal biofilm formation by synthetic small molecules | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 符文美,忻凌偉,鄧述諄 | |
dc.subject.keyword | 感染性心內膜炎,轉糖鏈球菌,生物膜,小分子合成物, | zh_TW |
dc.subject.keyword | infective endocarditis,Streptococcus mutans,biofilm,synthetic small molecules, | en |
dc.relation.page | 62 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2012-08-16 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf | 3.4 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。